Resource Library

Articles:

eBook:

Links:

Patent:

  • US 6,630,507 | Cannabinoids as Antioxidants and Neuroprotectants [Assignee: U.S. Department of Health and Human Services]

Press Releases – GW Pharma:

  • 06-05-19 | Positive Epidiolex Phase 3 Trial Results

Press Releases – PharmaCyte Biotech:

  • 05-13-19 | Cannabis Program Bioengineers Cell Line to Treat Cancers
  • 10-17-17 | Enzyme Activity Identified for Cannabis-Based Therapy
  • 04-10-17 | Significant Progress Seen in UNC Cannabis Research
  • 04-03-17 | Rabe Named Director of Cannabis Program Development
  • 12-27-16 | Cannabinoid Potential for Childhood Brain Cancers
  • 11-14-16 | UNC to Present at ACS 2017 Annual Meeting
  • 10-10-16 | Cannabinoid Research Shows Promise for Success
  • 09-01-16 | Cannabis Program Progress Reported
  • 08-02-16 | Rabe Presents at Cannabis Cancer Forum
  • 07-05-16 | Cannabis Research Supported by Scientific Article
  • 06-16-15 | Cannabis Research Advanced with Schedule 1 License
  • 03-01-15 | Rabe Discusses Targeted CIAB Cannabinoid Chemotherapy
  • 12-08-14 | Cannabis Subsidiary Name Changed to Viridis Biotech
  • 12-01-14 | Worldwide License for CIAB Cannabis-Based Treatments
  • 08-04-14 | Hyslop to Present at ACS 2014 Annual Meeting
  • 07-26-14 | Can Pot Fight Cancer? UNC Seeks the Answer.
  • 05-09-14 | Agreement with UNC to Develop Cannabis Treatments
  • 04-28-14 | Rabe Educates Fiduciaries on Medical Marijuana Benefits
  • 04-25-14 | Rabe Presents at UCSD Pain Medicine Grand Rounds
  • 04-08-14 | Rabe Speaks at ASA DC Unity Conference
  • 03-25-14 | Rabe to Present at ASA DC Unity Conference
  • 02-03-14 | CIAB for Cannabis Cancer Therapies
  • 01-14-14 | Hyslop Appointed to SAB
  • 12-30-13 | Rabe Develops SAB Charter
  • 12-26-13 | Rabe Appointed as SAB Chairman

Slide Decks:

Videos:

Contact